SFRP5 and type 2 diabetes mellitus: SFRP5 was identified by Cheng et al. [56] as a protective factor in the pathogenesis of autoimmune diabetes, suggesting it could facilitate a novel aspect of the treatment of patients with T2DM as well as latent autoimmune diabetes in adults.